了解和应用ESC/HFA指南在高级心力衰竭的管理中
Guillaume Baudry1,2,3, Nicolas Girerd1,3, Maja Cikes4
1Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique, INSERM 1433, CHRU de Nancy, Institut Lorrain du Coeur et des Vaisseaux, Nancy, France.
European journal of heart failure
|November 20, 2024
概括
心脏病学家对高级心力衰竭指南的认识有所不同,专家表现出更高的知识. 改善向三级医疗中心的转诊途径对于更好的患者结果至关重要.
科学领域:
- 心脏病学 心脏病学
- 心脏衰竭管理的管理
- 临床指南 临床指南
背景情况:
- 晚期心力衰竭 (HF) 的管理是复杂的,推延迟阻碍了最佳护理.
- 2021年欧洲心脏病学会/心力衰竭协会 (ESC/HFA) 的指导方针旨在规范高级心力衰竭护理.
- 了解心脏病专家当前的指南意识和实施是必不可少的.
研究的目的:
- 评估心脏病学家对2021年ESC/HFA高级心脏病指南的认识和应用.
- 确定导致晚期HF患者推迟转诊的障碍.
- 评估对机械循环支持 (MCS) 结果的看法.
主要方法:
- 在2023年6月至10月期间,通过ESC邮件列表向欧洲心脏病专家分发了一项在线调查.
- 受访者被分为心力衰竭心脏病专家 (HFC),一般心脏病专家 (GC) 或其他参与者 (OP).
- 该调查涵盖了指导知识,网络组织,临床病例管理和MCS感知.
主要成果:
- 与一般心脏病专家 (57%) 和其他专家 (62%) 相比,心力衰竭心脏病专家 (84%) 报告了更高的指导知识.
- 高碳化物更频繁地使用ESC/HFA标准 (76%) 进行高级HF识别,而不是GC (44%) 或OP (48%).
- 8.4%的HFCs认为将严重的HF患者转移到三级中心是困难的,而GC的19.6%和OP的18.2%是困难的.
结论:
- 心脏病学家之间存在大量的知识和应用差距,涉及到先进的HF指南.
- 需要有针对性的教育举措来改善对指导方针的遵守.
- 晚期HF患者的转诊过程需要优化,以确保及时获得专业护理.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
386
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
386
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:22Heart Failure Drugs: β-Blockers
316
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
01:22Heart Failure Drugs: Diuretics
343
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
343
01:28Mitral Regurgitation IV: Nursing Management
3
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
3
01:26Heart Failure Drugs: Inotropic Agents
521
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
521